Interleukin-32α induces migration of human melanoma cells through downregulation of E-cadherin

Joohyun Lee, Kyung Eun Kim, Soyoung Cheon, Ju Han Song, Younkyung Houh, Tae Sung Kim, Minchan Gil, Kyung Jin Lee, Seonghan Kim, Daejin Kim, Dae Young Hur, Yoolhee Yang, Sa Ik Bang, Hyun Jeong Park, Dae Ho Cho

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Interleukin (IL)-32α, the shortest isoform of proinflammatory cytokine IL- 32, is associated with various inflammatory diseases and cancers. However, its involvement in human melanoma is not understood. To determine the effect of IL- 32α in melanoma, IL-32α levels were examined in human melanoma cell lines that exhibit different migratory abilities. IL-32α levels were higher in human melanoma cell lines with more migratory ability. An IL-32α-overexpressing G361 human melanoma cell line was generated to investigate the effect of IL-32α on melanoma migration. IL-32α-overexpressing G361 cells (G361-IL-32α) exhibit an increased migratory ability compared to vector control cells (G361-vector). To identify factors involved in IL-32α-induced migration, we compared expression of E-cadherin in G361-vector and G361-IL-32α cells. We observed decreased levels of E-cadherin in G361-IL-32α cells, resulting in F-actin polymerization. To further investigate signaling pathways related to IL-32α-induced migration, we treated G361-vector and G361-IL-32α cells with PD98059, a selective MEK inhibitor. Inhibition of Erk1/2 by PD98059 restored E-cadherin expression and decreased IL-32α-induced migration. In addition, cell invasiveness of G361-IL-32α cells was tested using an in vivo lung metastasis model. As results, lung metastasis was significantly increased by IL-32α overexpression. Taken together, these data indicate that IL-32α induced human melanoma migration via Erk1/2 activation, which repressed E-cadherin expression. Our findings suggest that IL-32α is a novel regulator of migration in melanoma.

Original languageEnglish
Pages (from-to)65825-65836
Number of pages12
JournalOncotarget
Volume7
Issue number40
DOIs
Publication statusPublished - 2016

Fingerprint

Interleukins
Cadherins
Melanoma
Down-Regulation
Cell Line
Neoplasm Metastasis
Lung
Mitogen-Activated Protein Kinase Kinases

Keywords

  • E-cadherin
  • Erk1/2
  • Interleukin-32
  • Melanoma
  • Migration

ASJC Scopus subject areas

  • Oncology

Cite this

Interleukin-32α induces migration of human melanoma cells through downregulation of E-cadherin. / Lee, Joohyun; Kim, Kyung Eun; Cheon, Soyoung; Song, Ju Han; Houh, Younkyung; Kim, Tae Sung; Gil, Minchan; Lee, Kyung Jin; Kim, Seonghan; Kim, Daejin; Hur, Dae Young; Yang, Yoolhee; Bang, Sa Ik; Park, Hyun Jeong; Cho, Dae Ho.

In: Oncotarget, Vol. 7, No. 40, 2016, p. 65825-65836.

Research output: Contribution to journalArticle

Lee, J, Kim, KE, Cheon, S, Song, JH, Houh, Y, Kim, TS, Gil, M, Lee, KJ, Kim, S, Kim, D, Hur, DY, Yang, Y, Bang, SI, Park, HJ & Cho, DH 2016, 'Interleukin-32α induces migration of human melanoma cells through downregulation of E-cadherin', Oncotarget, vol. 7, no. 40, pp. 65825-65836. https://doi.org/10.18632/oncotarget.11669
Lee, Joohyun ; Kim, Kyung Eun ; Cheon, Soyoung ; Song, Ju Han ; Houh, Younkyung ; Kim, Tae Sung ; Gil, Minchan ; Lee, Kyung Jin ; Kim, Seonghan ; Kim, Daejin ; Hur, Dae Young ; Yang, Yoolhee ; Bang, Sa Ik ; Park, Hyun Jeong ; Cho, Dae Ho. / Interleukin-32α induces migration of human melanoma cells through downregulation of E-cadherin. In: Oncotarget. 2016 ; Vol. 7, No. 40. pp. 65825-65836.
@article{217f13706a644088893f46cac4c547ba,
title = "Interleukin-32α induces migration of human melanoma cells through downregulation of E-cadherin",
abstract = "Interleukin (IL)-32α, the shortest isoform of proinflammatory cytokine IL- 32, is associated with various inflammatory diseases and cancers. However, its involvement in human melanoma is not understood. To determine the effect of IL- 32α in melanoma, IL-32α levels were examined in human melanoma cell lines that exhibit different migratory abilities. IL-32α levels were higher in human melanoma cell lines with more migratory ability. An IL-32α-overexpressing G361 human melanoma cell line was generated to investigate the effect of IL-32α on melanoma migration. IL-32α-overexpressing G361 cells (G361-IL-32α) exhibit an increased migratory ability compared to vector control cells (G361-vector). To identify factors involved in IL-32α-induced migration, we compared expression of E-cadherin in G361-vector and G361-IL-32α cells. We observed decreased levels of E-cadherin in G361-IL-32α cells, resulting in F-actin polymerization. To further investigate signaling pathways related to IL-32α-induced migration, we treated G361-vector and G361-IL-32α cells with PD98059, a selective MEK inhibitor. Inhibition of Erk1/2 by PD98059 restored E-cadherin expression and decreased IL-32α-induced migration. In addition, cell invasiveness of G361-IL-32α cells was tested using an in vivo lung metastasis model. As results, lung metastasis was significantly increased by IL-32α overexpression. Taken together, these data indicate that IL-32α induced human melanoma migration via Erk1/2 activation, which repressed E-cadherin expression. Our findings suggest that IL-32α is a novel regulator of migration in melanoma.",
keywords = "E-cadherin, Erk1/2, Interleukin-32, Melanoma, Migration",
author = "Joohyun Lee and Kim, {Kyung Eun} and Soyoung Cheon and Song, {Ju Han} and Younkyung Houh and Kim, {Tae Sung} and Minchan Gil and Lee, {Kyung Jin} and Seonghan Kim and Daejin Kim and Hur, {Dae Young} and Yoolhee Yang and Bang, {Sa Ik} and Park, {Hyun Jeong} and Cho, {Dae Ho}",
year = "2016",
doi = "10.18632/oncotarget.11669",
language = "English",
volume = "7",
pages = "65825--65836",
journal = "Oncotarget",
issn = "1949-2553",
publisher = "Impact Journals",
number = "40",

}

TY - JOUR

T1 - Interleukin-32α induces migration of human melanoma cells through downregulation of E-cadherin

AU - Lee, Joohyun

AU - Kim, Kyung Eun

AU - Cheon, Soyoung

AU - Song, Ju Han

AU - Houh, Younkyung

AU - Kim, Tae Sung

AU - Gil, Minchan

AU - Lee, Kyung Jin

AU - Kim, Seonghan

AU - Kim, Daejin

AU - Hur, Dae Young

AU - Yang, Yoolhee

AU - Bang, Sa Ik

AU - Park, Hyun Jeong

AU - Cho, Dae Ho

PY - 2016

Y1 - 2016

N2 - Interleukin (IL)-32α, the shortest isoform of proinflammatory cytokine IL- 32, is associated with various inflammatory diseases and cancers. However, its involvement in human melanoma is not understood. To determine the effect of IL- 32α in melanoma, IL-32α levels were examined in human melanoma cell lines that exhibit different migratory abilities. IL-32α levels were higher in human melanoma cell lines with more migratory ability. An IL-32α-overexpressing G361 human melanoma cell line was generated to investigate the effect of IL-32α on melanoma migration. IL-32α-overexpressing G361 cells (G361-IL-32α) exhibit an increased migratory ability compared to vector control cells (G361-vector). To identify factors involved in IL-32α-induced migration, we compared expression of E-cadherin in G361-vector and G361-IL-32α cells. We observed decreased levels of E-cadherin in G361-IL-32α cells, resulting in F-actin polymerization. To further investigate signaling pathways related to IL-32α-induced migration, we treated G361-vector and G361-IL-32α cells with PD98059, a selective MEK inhibitor. Inhibition of Erk1/2 by PD98059 restored E-cadherin expression and decreased IL-32α-induced migration. In addition, cell invasiveness of G361-IL-32α cells was tested using an in vivo lung metastasis model. As results, lung metastasis was significantly increased by IL-32α overexpression. Taken together, these data indicate that IL-32α induced human melanoma migration via Erk1/2 activation, which repressed E-cadherin expression. Our findings suggest that IL-32α is a novel regulator of migration in melanoma.

AB - Interleukin (IL)-32α, the shortest isoform of proinflammatory cytokine IL- 32, is associated with various inflammatory diseases and cancers. However, its involvement in human melanoma is not understood. To determine the effect of IL- 32α in melanoma, IL-32α levels were examined in human melanoma cell lines that exhibit different migratory abilities. IL-32α levels were higher in human melanoma cell lines with more migratory ability. An IL-32α-overexpressing G361 human melanoma cell line was generated to investigate the effect of IL-32α on melanoma migration. IL-32α-overexpressing G361 cells (G361-IL-32α) exhibit an increased migratory ability compared to vector control cells (G361-vector). To identify factors involved in IL-32α-induced migration, we compared expression of E-cadherin in G361-vector and G361-IL-32α cells. We observed decreased levels of E-cadherin in G361-IL-32α cells, resulting in F-actin polymerization. To further investigate signaling pathways related to IL-32α-induced migration, we treated G361-vector and G361-IL-32α cells with PD98059, a selective MEK inhibitor. Inhibition of Erk1/2 by PD98059 restored E-cadherin expression and decreased IL-32α-induced migration. In addition, cell invasiveness of G361-IL-32α cells was tested using an in vivo lung metastasis model. As results, lung metastasis was significantly increased by IL-32α overexpression. Taken together, these data indicate that IL-32α induced human melanoma migration via Erk1/2 activation, which repressed E-cadherin expression. Our findings suggest that IL-32α is a novel regulator of migration in melanoma.

KW - E-cadherin

KW - Erk1/2

KW - Interleukin-32

KW - Melanoma

KW - Migration

UR - http://www.scopus.com/inward/record.url?scp=84994176938&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84994176938&partnerID=8YFLogxK

U2 - 10.18632/oncotarget.11669

DO - 10.18632/oncotarget.11669

M3 - Article

VL - 7

SP - 65825

EP - 65836

JO - Oncotarget

JF - Oncotarget

SN - 1949-2553

IS - 40

ER -